- Coordinator
- Ethnicon Metsovion Polytechnion, Greece
- Runs
- 1 January 2023 to 30 June 2026
- Status
- Running
- EU funding
- €4.4m
- Total cost
- €4.4m
- Partners
- 20 organisations in 7 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101093150
What the project is doing
In the project's own words, from its summary on CORDIS.
The bioreactor industry is currently flourishing with a global market valued estimated at 2.3 B€ in 2020 and predicted to exceed 6.6 B€ euro by 2030, growing at a rate of 10.7% CAGR. Despite this impressive growth, there are challenges which can significantly impede the further advancement of bioreactors: Bioproducts can be sustainable and competitive only if reliable and contamination-free production is ensured. Currently, there is no catholic solution to this issue.
To this end, LIBRA project introduces a benchtop smart multi-sensing system for the in-line automatable screening of cultivation processes in bioreactors. The LIBRA sensing technology lies in the use of light based integrated on-chip, real time sensors. A novel integration procedure of the photonic platforms together with disposable microfluidic modules and biofunctionalization units will result in a modular system with interchangeable components enabling the screening of nutrients and pathogens in bioreactor samples, according to the end users need.
Furthermore, the LIBRA system will be able to be attached and integrated to various bioreactor systems regardless of their form factors, spanning from stirred tank bioreactors to single use bioreactors (SUB). To achieve this, LIBRA will rely on a highly multi-disciplinary consortium comprising expertise and specialization in several fields spanning photonics, surface functionalization, microfluidics, advanced packaging and assembly, artificial intelligence and bioreactor manufacturers.
The exploitable results of LIBRA are expected to disrupt the current PIC-based sensing landscape, as estimated by the two business cases stemming from the project: the market revenues one year after the end of this project are expected to be €7.8 million growing to almost €59 million in 2032, and plethora of new IP and new business opportunities for the partners involved in the joint venture of LIBRA.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Ethnicon Metsovion Polytechnion | Athina | Greece | Coordinator |
| Csem Centre Suisse D'electronique Et De Microtechnique SA - Recherche Et Developpement | Neuchatel | Switzerland | Associatedpartner |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Aarhus Universitetshospital | Aarhus | Denmark | Participant |
| Optagon Fotoniki Idiotiki Kefalaiouchiki Etairia | Pallini, Athina | Greece | Participant |
| Phosprint Anonymi Etaireia | Agia Paraskevi Athina | Greece | Participant |
| Fibo Labs Oy | Helsinki | Finland | Participant |
| Ecovamed | Chaville | France | Participant |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Demcon Bunova B.v. | Enschede | Netherlands | Third party |
| Demcon Engineering BV | Enschede | Netherlands | Third party |
| Demcon Focal BV | Enschede | Netherlands | Third party |
| Demcon High-Tech Systems Enschede BV | Enschede | Netherlands | Third party |
| Demcon Industrial Systems Groningen BV | Enschede | Netherlands | Third party |
| Demcon Innovation & Technology B.v. | Enschede | Netherlands | Third party |
| Demcon Life Sciences & Health Enschede BV | Enschede | Netherlands | Participant |
| Demcon Life Sciences & Healtheindhoven B.v. | Best | Netherlands | Third party |
| Demcon Life Sciences & Health Maastricht B.V. | Enschede | Netherlands | Third party |
| Lionix International B.v. | Enschede | Netherlands | Participant |
| Scinus Cell Expansion Netherlands B.v. | Zeist | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI